Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Drug Safety
|
March 24, 2026
US Risk Evaluation and Mitigation Strategies with Elements to Assure Safe Use: A Longitudinal Analysis of REMS Modifications (2008-2022)
Elaine H Morrato, Elizabeth J Campagna, Cynthia LaCivita, et al.
Ethnicity & Disease
|
February 11, 2011
Medication assistance programs: do all in need benefit equally?
Maria Pisu, Katie Crenshaw, Ellen Funkhouser, et al.
Drug Safety
|
November 27, 2025
Prescription Drugs Subject to a Risk Evaluation and Mitigation Strategy: Patient Perspectives on Risk Communication and the Value of Educational Materials
Susan Chimonas, Carol Cosenza, Aaron S Kesselheim, et al.
Journal of the American Pharmacists Association : Japha
|
August 28, 2010
Patient-reported communications with pharmacy staff at community pharmacies: the Alabama NSAID Patient Safety Study, 2005-2007
Cynthia LaCivita, Ellen Funkhouser, Michael J Miller, et al.
Journal of Health Communication
|
June 25, 2010
Using single-item health literacy screening questions to identify patients who read written nonsteroidal anti-inflammatory medicine information provided at pharmacies
Michael J Miller, Jeroan J Allison, Michael R Schmitt, et al.
Journal of Hospital Medicine
|
October 15, 2010
Making inpatient medication reconciliation patient centered, clinically relevant and implementable: a consensus statement on key principles and necessary first steps
Jeffrey L Greenwald, Lakshmi Halasyamani, Jan Greene, et al.
Joint Commission Journal on Quality and Patient Safety
|
November 25, 2010
Making inpatient medication reconciliation patient centered, clinically relevant, and implementable: a consensus statement on key principles and necessary first steps
Jeffrey L Greenwald, Lakshmi K Halasyamani, Jan Greene, et al.
Drug Safety
|
January 27, 2026
Physician Awareness of FDA's Relaxation of REMS-Required Laboratory Testing Requirements and Changes in Prescribing Practices During the COVID-19 Pandemic
Catherine S Hwang, Zhigang Lu, Massimiliano Russo, et al.
Drug Safety
|
May 16, 2024
Trends in Use and Evidence of Adherence to Risk Evaluation and Mitigation Strategy Pregnancy Testing Requirements for Thalidomide, Lenalidomide, and Pomalidomide in the USA, 2000-2020
Mufaddal Mahesri, Ameet Sarpatwari, Krista F Huybrechts, et al.
JAMA Network Open
|
February 13, 2025
Physician Experiences With and Perspectives on Clozapine Prescribing
Ameet Sarpatwari, Zhigang Lu, Massimiliano Russo, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Drug Safety
|
March 24, 2026
US Risk Evaluation and Mitigation Strategies with Elements to Assure Safe Use: A Longitudinal Analysis of REMS Modifications (2008-2022)
Elaine H Morrato, Elizabeth J Campagna, Cynthia LaCivita, et al.
Ethnicity & Disease
|
February 11, 2011
Medication assistance programs: do all in need benefit equally?
Maria Pisu, Katie Crenshaw, Ellen Funkhouser, et al.
Drug Safety
|
November 27, 2025
Prescription Drugs Subject to a Risk Evaluation and Mitigation Strategy: Patient Perspectives on Risk Communication and the Value of Educational Materials
Susan Chimonas, Carol Cosenza, Aaron S Kesselheim, et al.
Journal of the American Pharmacists Association : Japha
|
August 28, 2010
Patient-reported communications with pharmacy staff at community pharmacies: the Alabama NSAID Patient Safety Study, 2005-2007
Cynthia LaCivita, Ellen Funkhouser, Michael J Miller, et al.
Journal of Health Communication
|
June 25, 2010
Using single-item health literacy screening questions to identify patients who read written nonsteroidal anti-inflammatory medicine information provided at pharmacies
Michael J Miller, Jeroan J Allison, Michael R Schmitt, et al.
Journal of Hospital Medicine
|
October 15, 2010
Making inpatient medication reconciliation patient centered, clinically relevant and implementable: a consensus statement on key principles and necessary first steps
Jeffrey L Greenwald, Lakshmi Halasyamani, Jan Greene, et al.
Joint Commission Journal on Quality and Patient Safety
|
November 25, 2010
Making inpatient medication reconciliation patient centered, clinically relevant, and implementable: a consensus statement on key principles and necessary first steps
Jeffrey L Greenwald, Lakshmi K Halasyamani, Jan Greene, et al.
Drug Safety
|
January 27, 2026
Physician Awareness of FDA's Relaxation of REMS-Required Laboratory Testing Requirements and Changes in Prescribing Practices During the COVID-19 Pandemic
Catherine S Hwang, Zhigang Lu, Massimiliano Russo, et al.
Drug Safety
|
May 16, 2024
Trends in Use and Evidence of Adherence to Risk Evaluation and Mitigation Strategy Pregnancy Testing Requirements for Thalidomide, Lenalidomide, and Pomalidomide in the USA, 2000-2020
Mufaddal Mahesri, Ameet Sarpatwari, Krista F Huybrechts, et al.
JAMA Network Open
|
February 13, 2025
Physician Experiences With and Perspectives on Clozapine Prescribing
Ameet Sarpatwari, Zhigang Lu, Massimiliano Russo, et al.
Page
of 2